FORIM

FORIM (Fondazione per la Ricerca in Medicina) is an Italian-based research organization and biotechnology entity focused on advancing clinical and translational research in oncology and hematology. The organization operates as a bridge between academic research and clinical application, frequently sponsoring and managing multi-center clinical trials for hematological malignancies. FORIM is particularly recognized for its extensive work in optimizing treatment protocols for Non-Hodgkin lymphoma and Chronic Lymphocytic Leukemia. By collaborating with international research groups and pharmaceutical partners, the foundation contributes to the development and validation of novel therapeutic regimens involving monoclonal antibodies and targeted small molecules.